Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Though surgical volumes were a sore spot for major for-profit health systems in the opening half of 2026, executives said this week they are optimistic those service lines will stay afloat for the | In fireside chats this week, leaders of the country's largest for-profit systems acknowledged a slowdown in demand that will generally continue through 2026. They also affirmed continued investments to meet future anticipated demand, particularly in ambulatory settings.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

The number of health services deals dipped in the first half of 2026 but deal value "remained resilient" as strategic acquirers…

Six months into 2026, the country’s third-largest nonprofit health system has grown its operating revenues by 8.6% but has seen a…

The tempo of healthcare bankruptcy filings during the front half of 2026 has increased slightly compared to last year, but the…

Hospitals’ operating margins improved from March to April but generally remain under siege as expenses rise and shifts in…

Hospital dealmaking remained hot during the second quarter of 2026, extending a merger and acquisition rebound that has lately…

Sixty-seven percent of healthcare system leaders are “very or extremely” concerned about Medicaid and Medicare reimbursement…